Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Birkmann

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Leukemia Research|January 1, 1986
Leukemic samples characteristics associated with clonogenic growthJ Birkmann, U Früh, V Hofmann
Geburtshilfe Und Frauenheilkunde|August 1, 1996
[Academic medical versus unconventional cancer therapy: anthropological viewpoints of an endless history]H Kappauf, J Birkmann, G Kaiser
Annals of Hematology|January 1, 1993
Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitroS Oez, J Birkmann, J R Kalden
Bone Marrow Transplantation|January 10, 2006
A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantationH Wandt, K Schaefer-Eckart, M Frank, et al.
Rheumatology International|July 20, 2011
Adult-onset Still's disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammationJ Rech, B Manger, B Lang, et al.
International Journal of Cancer|September 15, 1984
Incidence of double minutes, cytogenetic equivalents of gene amplification, in human carcinoma cellsE Gebhart, S Brüderlein, A H Tulusan, et al.
Clinical and Experimental Immunology|December 14, 2017
Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1T Hoeres, M Wilhelm, M Smetak, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted mediumJ Birkmann, S Oez, M Smetak, et al.
European Cytokine Network|July 1, 1993
Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell lineS Oez, G Hofmann-Wackersreuther, J Birkmann, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Leukemia Research|January 1, 1986
Leukemic samples characteristics associated with clonogenic growthJ Birkmann, U Früh, V Hofmann
Geburtshilfe Und Frauenheilkunde|August 1, 1996
[Academic medical versus unconventional cancer therapy: anthropological viewpoints of an endless history]H Kappauf, J Birkmann, G Kaiser
Annals of Hematology|January 1, 1993
Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitroS Oez, J Birkmann, J R Kalden
Bone Marrow Transplantation|January 10, 2006
A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantationH Wandt, K Schaefer-Eckart, M Frank, et al.
Rheumatology International|July 20, 2011
Adult-onset Still's disease and chronic recurrent multifocal osteomyelitis: a hitherto undescribed manifestation of autoinflammationJ Rech, B Manger, B Lang, et al.
International Journal of Cancer|September 15, 1984
Incidence of double minutes, cytogenetic equivalents of gene amplification, in human carcinoma cellsE Gebhart, S Brüderlein, A H Tulusan, et al.
Clinical and Experimental Immunology|December 14, 2017
Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1T Hoeres, M Wilhelm, M Smetak, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted mediumJ Birkmann, S Oez, M Smetak, et al.
European Cytokine Network|July 1, 1993
Granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the density of stem cell factor receptors (c-kit oncogene product) on a GM-CSF-dependent human myeloid cell lineS Oez, G Hofmann-Wackersreuther, J Birkmann, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.
Pageof 3